Arch Therapeutics: Arch Therapeutics to Present AC5 Advanced Wound System at the 2024 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)

FRAMINGHAM, Mass., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), a marketer and developer of novel self-assembling wound care and biosurgical products, today announced that the Company's commercial product, AC5® Advanced Wound System ("AC5"), will be featured at the 2024 Symposium on Advanced Wound Care Fall Meeting ("SAWC Fall"), which takes place at Caesars Palace, Las Vegas, from October 2-5, 2024.SAWC participants include doctors, nurses, and members of industry. Arch's team will demonstrate AC5 Advanced Wound System at our booth (#334) in the main exhibit hall and elsewhere during the conference.Another purpose of our participation in SAWC is to continue ongoing meetings with wound care and other life science companies that are interested in Arch's patented wound care products and novel approach to wound healing.Terrence W. Norchi, MD, President and CEO of Arch Therapeutics, said, "AC5 is a new and easy-to-use option for many doctors who treat patients in the operating room or in their office. With its self-assembly mechanism of action, AC5 provides a differentiated approach to the management of both acute surgical and chronic wounds. The potential importance of AC5 is underscored by the sheer number of people with non-healing wounds, thought to exceed 6 million in the US alone."On Friday, October 4, 2024, the following clinical cases, which further demonstrates the use of AC5 in patients with challenging wounds, will be presented during the poster viewing session:Successful Management of Tunneling Wounds with the use of Synthetic Self-assembling Peptide Matrix.By Dr. Misael C. Alonso, MD, FACP, CWSP, FAPWCAPoster #C-007A Pilot Study of Lower Extremity Wounds Utilizing a Novel Nanoparticle Self-Assembling Peptide.by Eric J. Lullove, DPM, CWSP, DABLES, FAPWH(c), FFPM, RCPS (Glasg)Poster #: CR-032Norchi ...Full story available on Benzinga.com